Insider Transactions Reported by 17 Insiders of Stoke Therapeutics, Inc.

Symbol
STOK on Nasdaq
Location
Bedford, MA

Insiders trading volume in the past year

Stoke Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Skorpios Trust 10%+ Owner $39,843,046 -$30,600,000 -43% 04 Jun 2025
Adrian R. Krainer Director $12,554,744 -$2,581,492 -17% 02 Mar 2026
Edward M. Kaye MD Director $3,133,917 -$4,410,616 -58% 08 Dec 2025
Barry Ticho Chief Medical Officer $1,096,882 -$1,248,585 -53% 17 Feb 2026
ARTHUR A. LEVIN Director $785,183 31 Dec 2025
Stephen J. Tulipano Former CFO $757,722 27 Mar 2024
Huw M. Nash Chief Business Officer $631,200 02 Jul 2024
Thomas Leggett Chief Financial Officer $487,930 17 Feb 2026
Jonathan Allan General Counsel & Corp Sec $487,061 -$1,540,566 -76% 17 Feb 2026
Jason Hoitt Chief Patient Officer $17,533 17 Feb 2026
Jennifer Burstein Director 03 Jun 2025
Garry E. Menzel Director 03 Jun 2025
IAN F. SMITH Chief Executive Officer, Director 17 Feb 2026
Julie Smith Director 03 Jun 2025
Seth Loring Harrison Director 03 Jun 2025
ATP Life Science Ventures, L.P. 10%+ Owner 28 Jun 2021
ARTHUR TZIANABOS Interim Executive Chair, Director 20 Mar 2025

Recent Insider Transactions by Companies or Individuals for Stoke Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.